Platelet-rich plasma use for shoulder epicondylitis treatment

Cover Page


Epicondylitis is the most common cause of elbow pain, affecting up to 3,0% of the adult population. A comparative study of platelet-rich plasma (BTP) and betamethasone (diprospan) in the treatment of epicondylitis of the shoulder. 50 patients received injections of betamethasone 2-fold with an interval of 14 days. The main group-50 patients received 2 injections of BTP with an interval of 14 days. The results were evaluated using the psychometric scale Patient-Rated Tennis Elbow Evaluation (PRTEE) after 1, 6 and 12 months. Patients receiving Betamethasone showed the lowest level of pain after 1 month, with a gradual tendency to reduce the clinical effect after 6 months and the increase in clinical symptoms of the disease after 12 months. after treatment. The clinical effect after the use of BTP increases to 6 months with a slight tendency to reduce the effect to 12 months. Our studies have shown a high, up to 86,0% effectiveness of the applied methods of treatment of internal and external epicondylitis of the shoulder using PRP in comparison with glucorticosteroids.

About the authors

A. A. Ochkurenko

National medical research center for traumatology and orthopedics named after N.N. Priorov

Author for correspondence.

Russian Federation, Moscow

S. N. Savelyev

Clinical Hospital №6


Russian Federation, Izhevsk

T. O. Baymatov

National medical research center for traumatology and orthopedics named after N.N. Priorov


Russian Federation, Moscow


  1. Shiri R, Viikari-Juntura E, Varonen H, Heliövaara M. Preva- lence and determinants of lateral and medial epicondylitis: a population study. Am J Epidemiol. 2006;164(11):1065–1074. doi: 10.1093/aje/kwj325.
  2. Беленький А.Г. Эпикондилит // РМЖ. — 2006. — Т.14. — №25. — C. 1786. [Belen’kii AG. Epikondilit. RMZh. 2006;14(25):1786. (In Russ).]
  3. Varshney A, Maheshwari R, Juyal A, et al. Autologous platelet-rich plasma versus corticosteroid in the manage- ment of elbow epicondylitis: a randomized study. Int J Appl Basic Med Res. 2017;7(2):125–128. doi: 10.4103/2229- 516X.205808.
  4. Наговицын Е.С. Осложнения после местного применения гидрокортизона // Клiнiчна хiрургiя. — 1977. — №3. — С. 51–53. [Nagovitsyn ES. Oslozhneniya posle mestnogo primeneniya gidrokortizona. Klin Khir. 1977;(3):51–53. (In Russ).]
  5. Saccomanni B. Corticosteroid injection for tennis elbow or lateral epicondylitis: a review of the literature. Curr Rev Musculoskelet Med. 2010;3(1–4):38–40. doi: 10.1007/s12178- 010-9066-3. RETRACTION IN Erratum to: Corticosteroid injection for tennis elbow or lateral epicondylitis: a review of the literature. [Curr Rev Musculoskelet Med. 2012]
  6. Edwards SG, Calandruccio JH. Autologous blood injec- tions for refractory lateral epicondylitis. J Hand Surg Am. 2003;28(2):272–278. doi: 10.1053/jhsu.2003.50041.
  7. Мозолевский Ю.В. Ботокс возвращает на корт // Теннис и гольф. — 2000. — №3. — С. 5. [Mozolevskii YuV. Botoks vozvrashchaet na kort. Tennis i gol’f. 2000;(3):5. (In Russ).]
  8. Galvin R, Callaghan C, Chan WS, et al. Injection of botu- linum toxin for treatment of chronic lateral epicondylitis: systematic review and meta-analysis. Semin Arthritis Rheum. 2011;40(6):585–587. doi: 10.1016/j.semarthrit.2011.01.003.
  9. Wong SM, Hui AC, Tong PY, et al. Treatment of lateral epi- condylitis with botulinum toxin: a randomized, double-blind, placebo-controlled trial. Ann Intern Med. 2005;143(11):793– 797. doi: 10.7326/0003-4819-143-11-200512060-00007.
  10. Tosun HB, Gumustas S, Agir I, et al. Comparison of the effects of sodium hyaluronate-chondroitin sulphate and cor- ticosteroid in the treatment of lateral epicondylitis: a prospec- tive randomized trial. J Orthop Sci. 2015;20(5):837–843. doi: 10.1007/s00776-015-0747-z.
  11. Chung B, Wiley JP. Effectiveness of extracorporeal shock wave therapy in the treatment of previously untreated lateral epicondylitis: a randomized controlled trial. Am J Sports Med. 2004;32(7):1660–1667. doi: 10.1177/0363546503262806.
  12. Kazemi M, Azma K, Tavana B, et al. Autologous blood ver- sus corticosteroid local injection in the short-term treatment of lateral elbow tendinopathy: a randomized clinical trial of efficacy. Am J Phys Med Rehabil. 2010;89(8):660–667. doi: 10.1097/PHM.0b013e3181ddcb31.
  13. Wolf JM, Ozer K, Scott F, et al. Comparison of autologous blood, corticosteroid, and saline injection in the treatment of lateral epicondylitis: a prospective, randomized, controlled multicenter study. J Hand Surg Am. 2011;36(8):1269–1272. doi: 10.1016/j.jhsa.2011.05.014.
  14. Guler NS, Sargin S, Sahin N. Efficacy of extracorpore- al shockwave therapy in patients with lateral epicondylitis: a randomized, placebo-controlled, double-blind clinical trial. North Clin Istanb. 2018;5(4):314–318. doi: 10.14744/ nci.2017.82435.
  15. Pietrzak WS, Eppley BL. Platelet rich plasma: biology and new technology. J Craniofac Surg. 2005;16(6):1043–1054. doi: 10.1097/
  16. Eppley BL, Woodell JE, Higgins J. Platelet quantification and growth factor analysis from platelet-rich plasma: implications for wound healing. Plast Reconstr Surg. 2004;114(6):1502– 1508. doi: 10.1097/01.prs.0000138251.07040.51.
  17. Rompe JD, Overend TJ, MacDermid JC. Validation of the patient-rated tennis elbow evaluation questionnaire. J Hand Ther. 2007;20(1):3–10. doi: 10.1197/j.jht.2006.10.003.
  18. Pruce AM, Miller JA, Berger IR. Anatomic landmarks in joint paracentesis. Clin Symp. 1964;16:19–30.
  19. Chen X, Jones IA, Park C, Vangsness CT Jr. The ef- ficacy of platelet-rich plasma on tendon and ligament healing: a systematic review and meta-analysis with bias assessment. Am J Sports Med. 2018;46(8):2020–2032. doi: 10.1177/0363546517743746.
  20. Houck DA, Kraeutler MJ, Thornton LB, et al. Lateral epicon- dylitis with autologous blood, platelet-rich plasma, or corti- costeroid injections: a systematic review of overlapping meta- analyses. Orthop J Sports Med. 2019;7(3):2325967119831052. doi: 10.1177/2325967119831052.



Abstract - 128

PDF (Russian) - 44


Article Metrics

Metrics Loading ...


  • There are currently no refbacks.

Copyright (c) 2020 Ochkurenko A.A., Savelyev S.N., Baymatov T.O.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies